Andrew Selfridge, MPH MBA PhD, is a results-driven global clinical development leader with a passion for delivering innovative therapies to patients. With extensive experience overseeing multicenter global clinical trials across various therapeutic areas, they have engaged with regulatory authorities such as the FDA and EMA to ensure compliance and successful study execution. Andrew's educational background includes a BSc, MPH, PhD, and an Executive MBA, complemented by a postdoctoral fellowship, reflecting a robust scientific foundation and strategic business acumen. Currently, Andrew serves as the Global Development Lead at Pfizer, guiding the clinical development strategy across immunology assets. Having lived and worked on four continents, they excel in cross-functional teams, translating complex science into impactful therapies for diverse patient populations.
This person is not in any teams
This person is not in any offices